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AbstrAct
Infectious diseases have had a great impact on human lives and civilizations 
since time immemorial. Success in controlling and eradicating these diseases, 
on the other hand, has not only overcome human misery but expedited human 
progress, both individually and collectively. The eradication of smallpox and 
the successful control of poliomyelitis and hepatitis B can even be measured in 
terms of the improvement in the world’s GDP.  However, new and re-emerging 
infections, including those connected to livestock such as the Nipah virus, 
SARS and avian influenza, remind us to be ever vigilant and responsive to new 
threats.  The Newcastle disease virus (NDV) causes a highly contagious and fatal 
respiratory disease in chickens and other types of birds and affects the poultry 
industry worldwide.  Although this virus is effectively controlled by vaccination, 
it is still endemic in Malaysia and outbreaks of the disease have contributed to 
major losses for the poultry industry in the country in terms of mortality and 
loss in egg and meat production.  By delineating the genome of this enveloped 
negative single-stranded RNA virus, various genes have been sequenced, 
cloned and expressed in plasmid vectors in various organisms.  Knowledge of 
the structural and biological characterization of NDV has provided insights into 
various applications of this virus in the prevention and treatment of NDV and 
other diseases as well. Although the virus replicates poorly in normal human 
cells, causing mild respiratory disease and conjunctivitis, it replicates very well in 
human cancer cells. This provides a potential for its use in oncology.  Cancer is 
an omnipresent threat to human lives, especially with, but not limited to, ageing, 
a worldwide modern phenomenon. Its control and eradication remain largely 
elusive, requiring considerable concerted efforts from everyone. The oncolytic 
activities of the virus against human malignancies lead to tumor apoptosis and 
cell death. In this respect, work is in progress to leverage NDV as a viral vector 
to express and deliver foreign genes for vaccination and gene therapy purposes 
for specific malignancies in humans. This of course opens up a whole new vista 
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in research and industry, stretching imaginations and human potentials farther, 
with the cherished hope of improving the lives of human beings further.  
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IntroductIon
“We have the choice to use the gift of our lives to make the world a better place 
– Warner Arber, Nobel Laureate
Over the last millennium, man has seen remarkable contributions from scientists 
to make the world what it is today.  Perhaps one of the greatest achievements is 
the improvement of our living standards, eradication of infectious viral diseases 
such as smallpox and control of poliomyelitis, measles and hepatitis B.  Whilst 
we revel in these marvelous milestones, we need to take note of menacing and 
damaging developments, in particular emerging or re-emerging diseases, such 
as the Nipah virus, SARS, haemorrhagic dengue fever and avian influenza, within 
Asia.  Joshua Lederburg once commented that viruses are humanity’s only real 
competitors for dominion of our planet, serving both as parasites and genetic 
elements in their hosts (Lederburg, 1994).  They have considerable plasticity 
in their genetic make-up and in metabolic interactions in their hosts and are 
capable of rapid evolution.  Together with the increase in air transport and the 
clearing of our jungles to make room for an ever increasing population, the 
threat of an outbreak of these diseases and even new ones seem to be even 
greater than ever before! These viruses are potential and powerful destroyers 
of our livestock and ultimately our lives, through their impact on the economy 
and health of nations.
 Malaysian consumers today demand safe and high quality food at reasonable 
prices from the industry. Chicken meat is the most popular and cheapest 
source of meat protein among Malaysians, largely because there are no dietary 
prohibitions or religious restrictions against the consumption of chicken 
(table 1). Over the years, fast food restaurants (QSR) such as Kentucky Fried 
Chicken (KFC), McDonald’s, A&W, Kenny Rogers and Nando’s Chickenland 
have significantly increased the consumption of chicken in Malaysia. The 
poultry industry in Malaysia has an approximate total revenue of RM 5 billion 
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annually.  Nevertheless, the industry is often hampered by outbreaks of various 
viral diseases such the avian influenza virus, infectious bronchitis virus, chicken 
anemia virus and the Newcastle disease virus (NDV).  
table 1   Sources of protein for human consumption
  Poultry Fish Lamb beef Pork
Expensive 7 7 3 3 7
Seasonal 7 3 7 7 7
Acceptance 3 3 7 7 7
Note: 3 = agree; 7 = do not agree
 NDV is an economically important avian paramyxovirus that causes a highly 
contagious respiratory and neurological disease which is often fatal to many 
bird species (Alexander, 1999). It belongs to the same family as the Nipah 
virus (NiV), measles virus, mumps virus, human parainfluenza virus and the 
respiratory syncytial virus (Figure 1).  
Figure 1  Phylogenetic tree showing the relationship between NDV and other 
paramyxoviruses.
Genus Respirovirus
Genus Morbillivirus
Genus Henipahvirus
Genus Rubulavirus
Genus Avulavirus
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 Reports of recent outbreaks in many countries such as England, France and 
Malaysia (OIE homepage; http://www.oie.int), often resulting in mass culling, 
prove that NDV is a continuing threat to the worldwide poultry industry. In 
Malaysia alone, the disease caused by NDV can amount to over RM 100 million 
in costs annually.  Hence, a constant surveillance and vaccination programme, 
especially in countries such as Malaysia where the disease appears to be 
endemic, is needed. 
 NDV can infect many species of birds. The virus is spread primarily through 
direct contact, by ingestion and inhalation and can be categorized into three 
main pathotypes based on the severity of the disease. Lentogenic isolates do 
not usually cause any disease in adult birds and are considered to be mildly 
virulent or avirulent. Viruses of intermediate virulence that cause respiratory 
disease are termed mesogenic, while virulent strains that cause high mortality 
are termed velogenic. Neurotropic and viscerotropic velogenic strains cause 
severe intestinal lesions with neurological disease, resulting in high mortality 
(up to 100% in chickens).   We have been working on the molecular biology of 
a velogenic neutropic-viscerotropic local isolate known as strain AF2240.  This 
virus which was isolated in the 1960’s (Lai, 1985) can be grown and purified 
simply and efficiently (Mohd. Esa et al., 1996).  The genome of strain AF2240 
has been fully sequenced (Yusoff and Tan, 2001) and individual genes were 
cloned and expressed in various plasmid vectors to understand their interactions 
between each other as well as with the host proteins.  
 Based on years of research dedicated to avian viruses, our research team 
has developed, patented and commercialised several diagnostic assays and 
vaccines against many of these viruses (table 2).  One of the outstanding 
discoveries made while studying these viral proteins is that the nucleocapsid 
(NP) of the virus can form ring-like structures which have the ability to carry 
foreign proteins on its outer structure (Kho et al., 2001b).  Various proteins have 
been attached to the NP, and it was shown that these proteins are immunogenic 
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and can illicit immune responses against various other pathogens (Rabu et al., 
2002; Sivasamugham et al., 2003; 2006).  Thus, NDV can serve as a vector to 
express and deliver foreign genes for vaccination and gene therapy purposes. 
table 2a   Products commercialised, prototypes and trademarks, patents and 
activities on avian research by the Avian Virus Research Group in UPM
A. Products Commercialised
 1. Newcastle disease vaccine
 2. Fowl pox vaccine
 3. Infectious bursal disease vaccine
B. Prototypes    
 1. IBDReal check, a diagnostic kit for the detection of infectious bursal disease virus 
subtypes. 
 2. FluReal H9N2 check, a diagnostic kit for the detection of type A avian influenza 
virus and subtyping of H9N2 virus. 
 3. NDReal check, a diagnostic kit for the detection of Newcastle disease virus 
pathotypes. 
 4. FluReal H5N1 check, a diagnostic kit for the detection of type A avian influenza 
virus and subtyping of H5N1 virus. 
 5. NDPath, a diagnostic kit for the detection of Newcastle disease virus
 6. ViroRapid, a nested RT-PCR detection for Newcastle disease virus
 7. BioCarrier, a novel drug delivery system
C. Malaysian Trademarks     
      1. NDPathTM in Class 5; Application No:  05007201; Filing Date: 9 May 2005
 2.  BioCarrierTM in Class 5; Application No:  05007202; Filing Date:  9 May 2005
 3. Real checkTM, Rapid, Economical and Leader in Animal Diagnostics in Class 5; 
Application No: 06015350; Filing Date:  29 Aug 2006 
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table 2b   Patent deposits by the Avian Virus Research Group in UPM
overseas Patents
1. Invention:  Nucleocapsid (NP) and phosphoprotein (P) genes of a Malaysian velogenic 
Newcastle disease virus strain AF2240; usA Patent no:  6,939,957; Date granted: 
6 September 2005; Country: USA
2. Invention: Methods for detection and differentiation of infectious bursal disease virus; 
Application No: 11/268,341; Filing Date: 17 November 2005; Country:  USA
3. Invention : Methods for detection and differentiation of infectious bursal  virus; 
Application No: 05256888.8; Filing Date: 7 November 2007; Country: Europe
Malaysian Patents
1. Invention:  Nucleotide sequences of the nucleocapsid (NP) and phosphoprotein 
(P) genes of a Malaysian velogenic Newcastle disease virus strain AF2240 and the 
production of the NP and P proteins in Escherichia coli; Malaysian Patent no: 
MY-125227-A; Date granted:  31 July 2006
2. Invention: Detection of Newcastle disease virus;  Application No:  PI 20005526; Filing 
Date:  27 Nov 2000
3. Invention: Peptides that inhibit the propagation of Newcastle disease virus ;  Application 
No:  PI 20013687; Filing Date: 6 August 2001
4. Invention: Nucleocapsid protein of Newcastle disease virus as a carrier for 
immunogens; Application No:  PI 20005526; Filing Date:  11 May 2002
6. Invention:  Methods for detection and differentiation of infectious bursal disease virus; 
Application No: PI 20062120; Filing Date:  5 November 2004
5. Invention : Detection and subtyping of H9N2 influenza virus type A by molecular 
biology method; Application No: PI 20062120; Filing Date: 9 May 2006
7. Invention: Rapid detection and differentiation of Newcastle disease virus pathotypes; 
Application No: PI 20070884; Filing Date: 5 June 2007
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table 2c   Research activities by the Avian Virus Research Group in UPM
newcastle disease virus
1. Genome and functional analyses of Newcastle disease virus
2. Development of novel therapeutic and diagnostic reagents from Newcastle disease 
virus
3. Characterisation and pathogenicity of paramyxovirus 
4. Molecular characterisation of Newcastle disease and infectious bronchitis viruses
5. Molecular characterisation of Newcastle disease virus
6. Molecular biology of viruses of veterinary importance
7. Identification of Newcastle disease virus by RNA- polymerase chain reaction
8. Location of antibody neutralisation sites in Newcastle disease virus  
9. Cloning and rapid sequence analysis of cDNA
10. Development and  improvement of Newcastle disease vaccine – strain F
11. Vaccination of village chickens against Newcastle disease
12. Establishment of improved methods for the diagnosis of livestock diseases in 
Southeast Asia using ELISA 
13. Upscaling of food based Newcastle disease vaccine 
14. Effect of recombinant glycoproteins of Newcastle disease virus on cancer cells
15. Macromolecular interactions between different proteins of the Newcastle disease   
virus
16. Development of vaccine delivery platforms for tropical infectious diseases (To design 
and develop a Newcastle disease virus nucleocapsid-fusion sub-unit vaccine)
17. Determination of the L gene sequence and intergenic regions of Newcastle disease 
virus strain AF2240
Avian influenza virus
1. Characterisation and pathogenicity of avian influenza virus
2. Development of novel polymerase chain reaction based diagnostic tools for rapid 
detection of avian influenza
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3. Development of prototype vaccines against H5N1 and characterization of the vaccine 
induced responses
4. Genomic characterization of H5N1 viruses isolated from poultry farms
5. Development and clinical trials of prototype kits for laboratory detection of avian 
influenza viruses
Infectious bronchitis virus
1. Molecular characterisation of Newcastle disease and infectious bronchitis viruses
Fowlpox virus
1. Cloning of poultry viruses and development of improved fowl pox vaccine
chicken anemia virus
1. Molecular cloning and pathogenesis of chicken anaemia virus
2. Identification of chicken anemia virus genetic determinants associated with virus 
attenuation and pathogenicity
Infectious bursal disease virus
1. Development of an effective diagnosis tool and novel vaccine against infectious bursal 
disease virus infection
2. The dynamics of chicken T lymphocyte and cytokine responses following infection 
with very virulent infectious bursal disease virus
 Although the virus is very pathogenic to many species of birds, it replicates 
poorly in humans, causing mild respiratory disease and conjunctivitis (Alexander 
and Jones, 2001).  Nevertheless, once inside a susceptible cell, the virus 
replicates rapidly and selectively kills human tumors through apoptosis leading 
to cell death (Sinkovics and Horvath, 2000).   The interest in using NDV as an 
anti-cancer agent has increased steadily in recent years. For the past few years, 
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our team has also been working on the activities of the virus as an anti-cancer 
agent.  
 These vast advances in the structural and biological characterization of NDV 
in both normal and cancer cells have provided research opportunities to address 
various applications of this virus in the prevention and treatment of diseases. 
Let me relate how the lowly common domesticated chicken may help solve this 
puzzle.
VIrus cLAssIFIcAtIon And genoMe 
NDV is the prototype paramyxovirus belonging to the genus Avulavirus (de 
Leeuw and Peeters, 1999; Mayo, 2002) of the order Mononegavirales, family 
Paramyxoviridae, and subfamily Paramyxovirinae.  This enveloped virus is also 
called avian paramyxovirus type-1 (APMV-1) (Alexander, 1997).  Its negative-
sense single stranded nonsegmented RNA genome of  NDV contains 15186 
bases (Krishnamurthy and Samal, 1998; Phillips et al., 1998) which contains 
six structural genes that encode the nucleocapsid protein (NP),  phosphoprotein 
(P), matrix protein (M), fusion protein (F), haemagglutinin-neuraminidase 
protein (HN) and the large protein (L) in the order of  3’-leader-NP-P-M-F-
HN-L-trailer5’ (Figure 2) as well as two non-structural proteins, the W and V 
proteins (de Leeuw and Peeters, 1999; reviewed in Yusoff and Tan, 2001). These 
non-structural proteins result from transcriptional editing of the mRNA of the P 
gene, by insertion of one or two G residues to result in frameshifts (Steward et 
al., 1993; Locke et al., 2000). RNA sequencing studies revealed that the 3’ and 
5’ends of the genomic RNA respectively, contain a leader sequence and trailer 
sequence, which have been thought to be cis-regulatory elements in replication, 
transcription and packaging of the genomic and anti-genomic RNA (Blumberg et 
al., 1981; Chambers et al., 1986a; Lamb and Kolakofsky, 2001).  Separating these 
structural genes are intergenic regions of variable lengths (1 to 47 nucleotides) 
which are probably involved in terminating the mRNA transcription from the 
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preceding gene, before initiating transcription of the subsequent gene (Isihida 
et al., 1986; Millar et al., 1986; Yusoff et al., 1987; Philips et al., 1998).  
     
            complex
Figure 2  Schematic diagram of the virion structure of NDV showing the proteins 
involved in the transcriptive complex (Modified from Lamb and Kolakofsky, 2001; 
Yusoff and Tan, 2001; Fauziah et al., 2002).
 The viral RNA genome is encapsidated by the nucleocapsid protein (NP) 
(Mellon and Emmerson, 1978) to form an active ribonucleoprotein (NP:RNA) 
template core for its transcription and replication (Jahanshiri, unpublished data; 
2006). This template core together with the functional viral RNA dependent RNA 
polymerase, which comprises several copies of the P and L proteins (Yusoff 
and Tan, 2001), form a transcriptive complex. These three key components of 
❚❘❘ 
Newcastle Disease Virus: A Journey from Poultry to Cancer
the transcriptive complex of the virus have been the subject of studies for years 
because of their important roles at different stages of the virus life cycle.
ProteIns In the trAnscrIPtIVe coMPLex
a. nucleocapsid Protein (nP)
The NP protein is the most abundant protein in the virus. This protein is 
encoded by the NP gene which contains a single open reading frame (ORF) of 
1467 nucleotides (Ishida et al., 1986; Krishnamurthy and Samal, 1998; Kho et 
al., 2001a). The NP polypeptide comprises 489 amino acids and its molecular 
mass is 53 kDa.  Comparison of the predicted NP amino acid sequence with 
the other viruses indicated that it shares very low identity (<35%) with other 
paramyxoviruses but is highly identical (91 to 98%) to various NDV strains 
(Kho et al., 2001a).
 Electron microscopic analyses revealed that the NP protein appears as 
flexible helical structures (Figure 3a) with a diameter of about 18 nm and 1 
μm within the pleomorphic virions (Figure 3b). The NP structures resemble 
the classical herringbone morphology (Kho et al., 2001b) with spikes protruding 
from a central channel, surrounded by 2200 to 2600 NP subunits (Choppin and 
Compans, 1975; Yusoff and Tan, 2001). Several NP monomers expressed from 
Escherichia coli formed ring-like particles assembled to appear like “stacked 
doughnuts” in encapsidating the RNA genome. 
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(a)                                                               (b)
Figure 3   Electron micrographs of (a) the herringbone-like nucleocapsid and (b) 
pleomorphic NDV particles.  Bar represents 100 nm.  (From Yusoff and Tan, 2001; 
Courtesy of  Fauziah and Zolkapli; unpublished data)
 The NP protein interacts with itself to form a full length herringbone 
nucleocapsid.  A deletion mutagenesis approach was employed to define the 
contiguous sequence of the NP protein which is involved in self-assembly (Kho 
et al., 2003). A total of 11 deletion mutants with successive deletions from either 
the N- or the C-end of NP gene were constructed. C-terminal deletion constructs 
NP
∆C464, NP∆C440, NP∆C405, NP∆C391, NP∆C380, NP∆C375, NP∆C366 and NP∆C245 differed 
from the full-length NP by deletion of 25, 49, 84, 98, 109, 114, 123 and 244 
amino acids from the C terminus of the NP protein, respectively. N-terminal 
deletion mutants NP
∆N26, NP∆N122 and N∆PN245 were the result of 25, 121 and 244 
amino acid deletions from the N terminus of the NP protein, respectively. All of 
the truncated proteins were successfully expressed in E. coli TOP 10 cells and 
purified using ammonium sulphate and sucrose gradient methods. Electron 
microscopic examination of the truncated NP fragments revealed that the 
region of the NP protein required for proper folding to form a herringbone-like 
particle is located in the NP N-terminal end, encompassing amino acids 1 to 
375 (Figure 4).  Additionally, the first 26 amino acids within this N-terminal 
region are also involved in the interaction with the P protein (Kho et al., 2004). 
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In contrast, the C-terminal end covering amino acids 376 to 489 is dispensable 
for the formation of herringbone-like particles (Kho et al., 2003). In addition, the 
C-terminal portion of the NP protein was shown to be exposed on the surface 
of the ring-like particles as observed by immunogold labeling analysis under 
electron microscopy (Figure 5a; Kho et al., 2001b).   
Figure 4  Electron micrographs of N- and C-terminally truncated NP proteins. NP
∆C464 
showed the presence of ring and short herringbone-like particles. Similar structures 
were observed in NP
∆C440. Relatively longer herringbone-like particles were observed 
for NP
∆C405, NP∆C391, NP∆C380 and NP∆C375. NP∆N26 protein formed nearly homogeneous 
aggregates. No regular, ordered structures were seen in NP
∆N122, indicating complete loss 
of NP–NP interaction in this mutant. Bars represent 100 nm. (From Kho et al., 2003).
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 Kho et al. (2003) demonstrated that C-terminal truncated proteins 
(NP
∆C405, NP∆C391, NP∆C380 and NP∆C375) are self-assembled in vitro to form 
long herringbone-like particles. A construct designated as NP
∆C391fus which 
contained the first 391 amino acids of NP fused to 29 amino acids of a foreign 
peptide harbouring two kinds of epitopes (the myc tag and six His residues) 
was generated and expressed in E. coli.  Subsequent analysis of the purified 
recombinant protein indicated that the original long herringbone-like particles 
was remarkably shorter that that of non-fusion.  This observation suggests the 
possible role of the C-terminal end as a length determination region, and the 
C-terminus of NP protein seems to be flexible that the length of the herringbone-
like particles could be varied by simply deleting or inserting some amino acids! 
It was thus possible to construct various recombinant NP fusion proteins to 
deliver immunogenic regions such as hepatitis B core antigen (Kho, 2003), the 
Nipah virus N protein (Kho, 2003), the immunodominant regions of the VP1 of 
human enterovirus 71 (Sivasamugham et al., 2003) as well as NDV glycoproteins 
(Rabu et al., 2002) without impairing the formation of the ring-like structure. 
The potential use of such constructs as a molecular carrier in the development 
of diagnostic kits and vaccines will be discussed later.
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Figure 5  Transmission electron micrographs showing formation of  (A) ring- and (B) 
herringbone-like nucleocapsid structures of (i) NDV and (ii) NiV.  
(Modified from Kho et al., 2001b; Eshaghi et al., 2005a)
 Similarly, we have studied the genome of the local isolate of another 
paramyxovirus, the NiV (Abu Bakar et al., 2004) and showed that the C-terminal 
region of the nucleocapsid (N) protein in the Nipah virus (NiV) contains the 
major antigenic region when probed with antisera from humans and pigs 
infected naturally (Tan et al., 2004b). Solubility analysis of N- and C-terminally 
deleted mutants in several E. coli strains revealed that the full-length N protein 
has the highest solubility (Ong et al., 2002). To further study the N protein of 
NiV, a recombinant baculovirus was generated and transfected into Sf9 insect 
cells.   Electron microscopic analysis of the purified NiV N protein showed 
the presence of spherical and ring- and herringbone-like structures similar to 
A(i) b(i)
b(ii)A(ii)
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those of NDV (Figure 5ii). The purified nucleocapsids were polydispersed, 
and polymodal regression analysis indicated that they contained 96% small 
particles and 4% large particles. The buoyant density of the sample was found 
to be 1.08 ± 0.02 g/ml (Eshaghi et al., 2005a).   Furthermore, a phage clone 
bearing the heptapeptide, SNRTQGE which closely resembled the sequence at 
the C-terminal of the N protein was selected through biopanning experiments 
against antibodies in pooled sera of naturally NiV-infected swine.  This phage 
clone can be used as a novel diagnostic reagent in discriminating human and 
swine NiV sera-positive samples from sera-negative samples (Eshaghi et al., 
2005c). 
b. Phosphoprotein (P)
The polycistronic phosphoprotein (P) gene is located in second proximal to 
the 3’ end of the genome. The P gene is approximately 1450 nucleotides and 
encodes the P protein of 395 amino acids with a calculated molecular weight 
42 kDa (McGinnes et al., 1988). However, by SDS-PAGE analysis, the P protein 
has a relative mobility of 53-56 kDa (Kho et al., 2002). The acidic N-terminal 
domain of the P protein may account for this discrepancy (Curran et al., 1995a). 
As was mentioned earlier, two additional proteins, V and W, are expressed 
from mRNAs derived from transcriptional editing of the P gene (Samson et al., 
1991; Steward et al., 1993).  These two proteins share their amino (N) terminal 
domains with the P protein but vary at the carboxy (C) termini.  The V protein 
has a cysteine-rich C-terminal domain which binds to zinc (Steward et al., 1995). 
This domain also inhibits interferon response and plays a role in the inhibition 
of apoptosis in certain hosts (Park et al., 2003).
 It has been shown that the P proteins of many paramyxoviruses including 
NDV are oligomerized (Curran et al., 1995b; Jahanshiri et al., 2005). The 
oligomerized P protein interacts with the L protein and NP-RNA template to form 
the minimal transcription unit of paramyxoviruses (Curran, 1998; Tabouriech et 
❚❘❘ 
Newcastle Disease Virus: A Journey from Poultry to Cancer
al., 2000).  In the P-L complex, P acts as a cofactor that serves both to stabilize 
the L protein (Smallwood et al., 1994) and to place the polymerase complex (P-
L) on the NP-RNA template because the L protein by itself is unable to interact 
directly with the NP-RNA (Mellon and Emmerson, 1978; Horikami and Moyer, 
1995). Jahanshiri (unpublished data; 2006) showed that the C-terminal half of 
the NP protein (amino acids 292 to 338) is involved in the stabilization of the 
L protein.  
 In addition, the P protein inhibits NP self-assembly.  The unassembled NP 
(NP˚) is the active form of soluble NP protein used to assemble the nascent RNA 
chain during genome replication. When the P protein is in this NP˚-P complex, 
it inhibits NP self assembly, acting as a chaperon to prevent uncontrolled 
encapsidation of non-viral RNA by NP protein (Errington and Emmerson, 1997). 
To identify the domain(s) involved in the NDV P protein self-association and 
interaction with the NP, a yeast two-hybrid system was employed using full 
length P and its deletion derivatives (Jahanshiri et al., 2005). The 45 amino 
acids located at the C-terminal (amino acids 247 to 291), which is next to the L 
interactive region, seemed to be involved in both P:P as well as P:NP interactions 
(table 3).  
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  Table 3  P-P and NP-P interactions in the yeast two-hybrid system
 Full length and deletion mutants of Pa  ß-gal activity (%)b
                                                                           P:P  P:nP  
 P1-395 100  100
 P51-395 67  464
 P110-395 57        172
 P147-395 43        256
 P197-395 27        292
 P247-395 17        40
 P292-395 1        4
 P1-352 40        ND
c
 P1-291 50        352
 P1-246 1        8
 P1-196 1        12
 P197-291 40        16
                          
  a  The numbers in subscript indicate the amino acid residues cloned
  b  ß-gal activity of full length P clone was defined as 100%
  c Not determined
                  (From Jahanshiri et al., 2005)
                         
c. Large Protein (L)
The L protein, the largest but least abundant structural protein of NDV is coded 
by a 6700 bp gene and comprises 2204 amino acids with calculated molecular 
weight of approximately 249 kDa (Yusoff et al., 1987). The L protein possesses 
the RNA-dependent RNA polymerase activity and also encodes post-translational 
modification activities, such as capping, methylation and poly-adenylation 
of mRNAs (Yusoff and Tan, 2001).   Sequence alignment studies of all the L 
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proteins of non-segmented negative-strand RNA viruses revealed the presence 
of six highly conserved domains, I to VI, which are joined by variable non-
conserved regions (Poch et al., 1990; Sidhu et al., 1993).  In a comparative 
sequence analysis of the L genes, we suggested that the L proteins could exist 
in two different forms due to a compensatory mutation in the highly conserved 
Domain V (Kusumaningtyas et al., 2004).  This mutation significantly changed 
the hydrophobicity and total charge of the L protein.  It is possible that this 
change in the protein structure could be related to the role of the protein in 
replication and that this compensatory mutation is an adaptation process of the 
virus to restore fitness in the environment.  In a detailed analysis of these six 
domains within the transcriptive complex, Adzahar (unpublished data; 2006) 
showed that Domains III, IV and V interacted with both the P and NP proteins, 
but their levels of interaction were shown to be different.  Although these 
domains share extensive sequence similarity with corresponding domains in 
other L proteins, the precise roles of these conserved domains in the L protein 
have not been determined. 
MAtrIx ProteIn
The matrix protein is the smallest of the six structural proteins of NDV.  It forms 
the internal viral envelope and contains 364 amino acids with a calculated 
molecular weight of approximately 40 kDa (Chambers et al., 1986c; Seal et al., 
2000; unpublished data by Jemain, 1999).  This protein is believed to play an 
important role in the assembly of the virus, by interacting with the nucleocapsid 
of NDV, the lipid bilayer of the host cell and also the glycoproteins which are 
exposed on the inner surface of the membrane.  Although the M protein is 
not exposed to the significant immunological selection pressure, this protein 
exhibited antigenic variations which probably resulted from spontaneous 
mutations (Panshin et al., 1997). 
 ❘❘❚ 
Khatijah Yusoff
hn And F gLYcoProteIns
The HN and F glycoproteins are located on the envelope of the virus.  They 
are responsible for virus entry and fusion into the host cell membrane; the HN 
protein mediates attachment of the virus to the cell, and the F protein mediates 
fusion of the viral envelope with the cell membranes (Yusoff and Tan, 2001). 
They appear to be essential for the viral replication, and as such could represent 
the primary target for neutralizing antibodies as well as a potential target for 
antiviral agents (Ali et al., 1996).  We have shown that recombinant plasmids 
carrying the genes for both proteins were able to protect chickens against the 
virus (Loke et al., 2005). 
 The HN glycoprotein of NDV is a multifunctional protein.  It possesses 
receptor recognition and neuraminidase (NA) activities. It recognizes sialic-acid 
containing receptors on cell surfaces.  The NA removes the sialic acid in the 
virus to prevent it from self-agglutinating as well as promotes fusion activity of 
the F protein, thereby allowing the virus to penetrate the cell membrane (Yusoff 
and Tan, 2001). Nucleotide sequence analysis of the HN gene among 15 strains 
of NDV isolated in the past 50 years revealed that the whole HN gene comprises 
around 2000 nucleotides and carries an open reading frame encoding 571, 577, 
581 or 616 amino acids (Sakaguchi et al., 1989; Tan et al., 1995; Yusoff et al., 
1996). The largest of all, HN0616 can be converted to a biologically active HN 
protein by proteolytic cleavage of 45 residues from the C-terminus of the HN0 
precursor. However, the other three translation products of 571, 577 and 581 
amino acids are already in their active form and are usually found in virulent 
strains (Yusoff et al., 1997; Romer-Oberdorfer et al., 2003). Thus, in principle, 
the length of the HN protein could be a pathogenic determinant of NDV. However, 
its contribution to the virulence of the virus is still inconclusive (Estevez et al., 
2007).  
 Various monoclonal antibodies resistant mutants were used to delineate the 
antigenic sites (Chambers et al., 1988; Yusoff et al., 1988a,b; 1989a) as well 
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as locate the region involved in neuraminidase activity (Hughes et al., 1991). 
The HN glycoprotein is anchored in the viral envelope near its amino terminus 
(Lamb and Kolakofsky, 2001). Analysis of the HN gene showed that a stretch of 
amino acids ranging from 27 to 48 is highly hydrophobic, providing evidence 
for the amino terminal attachment of HN to the viral membrane (Yusoff and Tan, 
2001). In general, the HN protein contains six potential glycosylation sites, five 
of which are conserved among the paramyxoviruses (Tan et al., 1995; Yusoff et 
al., 1996). Two of these sites, at residues 341 and 481, were confirmed to be 
glycosylated from point mutation analysis and X-ray structural analyses (Yusoff 
et al., 1988b; Crennel et al., 2000).  The HN protein has been expressed in the 
Autographa californica unclear polyhedrosis virus (AcMNPV) derived vector 
under the control of the polyhedron promoter in infected Sf9 insect cells and 
shown to retain its biological, functional and immunological activities (Ong et 
al., 1999a;b).  
 The F glycoprotein is the major virulence factor for NDV (Romer-Oberdorfer 
et al., 2003).  It mediates fusion of the viral and cellular membranes synthesized 
as an inactive precursor, F0 containing 553 amino acids with a calculated 
molecular weight 55 kDa (Chambers et al., 1986b; Salih et al., 2000). This  F0 
precursor is proteolytically cleaved at the peptide bond of residues 116 and 117 
at a region known as the F0 cleavage site (GKQGR↓L), to generate two disulfide 
linked polypeptides, F1 (48 to 54 kDa) and F2 (10 to 16 kDa) by specific cellular 
proteases. This cleavage site on the F protein has been widely used for the 
identification of NDV (Yusoff et al., 1993; Kho et al., 2000; Khianizadeh et al., 
2002).  Unlike the HN, the transmembrane domain of the F glycoprotein, which 
anchors the protein in the membrane, is located near the C-terminus (residues 
501 to 527). Therefore it is not surprising that the major neutralizing epitopes 
are located on the N-terminal domain of the F protein based on results from 
reciprocal competitive binding assay between anti-F monoclonal antibodies 
and cross-resistance plaque assays of escaped mutants raised against these 
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antibodies (Yusoff et al., 1989b).   There are five to six potential glycosylation 
sites within the F glycoprotein. A conserved hydrophobic region of some 20 
residues known as fusion peptide is located at the amino terminus of the F1 
fragment. This region is thought to participate directly in the fusion of viral and 
host cell membranes (Lamb and Kolakofsky, 2001).  Like the HN protein, the 
recombinant F protein has also been expressed in Sf9 insect cells using the 
AcMNPV (Salih et al., 2001).  The recombinant virus was morphology distinct 
from the wild-type virus.  The expressed recombinant F protein was uncleaved 
but glycosylated and could be recognized by NDV polyclonal antibodies. 
Therefore, it will be possible to produce the recombinant F protein in large 
quantities through this expression system. 
MALAYsIAn IsoLAtes oF ndV
NDV has a large economic impact on the Malaysian poultry industry, ranging 
from losses due to disease and the expense of vaccination to the huge cost 
of diagnostic laboratory investigations. For this reason, a heat-resistant NDV 
variant, V4(UPM), was isolated following a heat selection process of the V4(Que) 
strain (Simmons, 1967) and was developed as a thermostable feed pellet vaccine 
(Aini et al., 1990). This is now commercially available to local farmers (table 
2; Figure 6). Most of the vaccine trials carried out in Malaysia use the strain 
AF2240 for challenge. This viscerotropic-velogenic NDV strain was first isolated 
from a local form field outbreak in the 1960s and was reported to cause high 
mortality and morbidity in poultry. This isolate differs from the other NDV isolates 
by having a different HN protein length (Tan et al., 1995). The two local isolates, 
AF2240 and V4 (UPM), show significant higher thermostability in HA, NA and 
infectivity (Tan et al., 1995; Yusoff et al., 1996; Tang et al., 2000). 
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Figure 6   Heat-stable vaccines against Newcastle disease virus 
(Courtesy of Aini Ideris)
IdentIFIcAtIon And dIFFerentIAtIon
An early diagnosis of NDV would allow more effective and timely control of the 
disease. The most widely used methods for NDV detection are routine serological 
tests such as virus neutralization and haemagglutination-inhibition (HI) assays 
(Alexander, 1989). Although these tests are relatively inexpensive and simple 
to prepare, they can be time consuming and lack the required sensitivity when 
sera from other species are tested.  Indirect enzyme-linked immunosorbent 
assays (ELISAs) have been frequently used to identify NDV. However it must be 
remembered that serological diagnosis is dependent on the expected immune 
status of the bird involved. Standardization of the results is often difficult to 
achieve since they depend on reference strains as well as reference antibodies. 
NDV specific antibodies are often not readily available to all laboratories. To 
address these problems, we have developed a reverse transcriptase-polymerase 
chain reaction (RT-PCR) method to detect the virus directly from infected allantoic 
fluids (Yusoff et al., 1993).  Later, a one-tube nested RT-PCR technique that 
is coupled with an ELISA-based colorimetric detection system was developed 
(Kho et al., 2000). The single tube used in this test not only saves time and cost 
but also reduces the chance of contamination, especially when large numbers 
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of samples are being analysed. Sensitivity and specificity is enhanced by 
subjecting the PCR products to a second round of PCR with an internal set of 
primers (nested PCR) based on the consensus sequence of the F gene sequence. 
Instead of detection by agarose gel electrophoresis, which is simple but is often 
used specially for high sample throughput, an alternative colorimetric detection 
method involving the use of biotin-avidin peroxidase was used. Samples can 
be readily analysed visually or by using an ELISA reader (Figure 7). It has 
been shown that the technique was more sensitive than the gel electrophoresis 
or the HI test. No cross-reactions with other avian viruses such as infectious 
bronchitis virus, infectious bursal disease virus, avian influenza virus and fowl 
pox virus were observed.  
Figure 7   ELISA test for NDV based nested RT-PCR.  Using nested primers, PCR 
products which have been labeled with biotin and digoxigenin could be captured onto 
stretavidin ELISA plates for colorimetric assay.  Samples which were positive with NDV 
produced a dark green colour (From Kho et al., 2000).  
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The efficacy of this nested PCR-ELISA technique was also compared with the 
conventional diagnostic tests for NDV (haemagglutination assay and non-nested 
RT-PCR)  by testing against tissue specimens collected from chickens with signs 
of NDV infection.  Results indicated that 60% of the tissue specimens were 
positive for NDV based on the nested RT-PCR whilst only 23% and 6% of them 
were positive by both the non-nested PCR and conventional haemagglutination 
assay, respectively. 
 As was mentioned earlier, extra amino acids can be attached to the C-terminus 
of the ring-like NP protein to become novel molecular carriers (Table 2a) for the 
presentation of epitopes in the development of diagnostics and sub-unit vaccines 
(Kho et al., 2001b; Rabu et al., 2002; Kho, 2003; Sivasamugham et al., 2006). 
Taking advantage of the fact that the recombinant  NP protein can be readily 
synthesised in E. coli without impairment of the overall morphology, a large 
scale purification technique using expanded bed adsorption chromatography 
was established (Tan et al., 2005, 2006a; b).  The protein can be purified directly 
from unclarified E. coli cells expressing the recombinant NP.  By comparing this 
new technique with the conventional multistep centrifugation method, we showed 
that not only was the processing time reduced from 56 hours to 7.5 hours, but 
that a protein yield of 9.6% with a purification factor of 6.6 was achieved.
 Similarly, various purification techniques and detection assays have been 
developed in our laboratory to grow and identify the avian poxvirus avian (Yusoff 
et al., 1992), influenza virus subtype H9N2 (Chaharaein et al., 2006) and NiV 
(Eshaghi et al., 2004a;b; 2005a;b;c; Ong et al., 2005; Tan et al., 2004b).  There 
are however some limitations, such as its inability to distinguish the various NDV 
pathotypes. Again, an extra sequencing step is required for phatotyping. Whilst 
the velogenic and mesogenic strains are pathogeneic, the lentogenic strains are 
avirulent and have been used as live vaccines to control the disease (Yusoff and 
Tan, 2001). However, current diagnosis of NDV is unable to differentiate virulent 
NDV in a vaccinated flock of chicken. The ability to distinguish virulent NDV 
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strains in flocks is important because international veterinary regulatory bodies 
require a definitive diagnosis of virulent NDV to enable effective prevention of 
an outbreak by strict control measures and trade embargo restrictions (Aldous 
and Alexander, 2001).  
 Thus far, pathotyping of  NDV strains involves the use of inoculated 
embryonated chicken eggs or chicks from which parameters such as mean 
death time (MDT), intracerebral pathogenicity index (ICPI) and intravenous 
pathogenicity index (IVPI) are determined (Alexander, 2001). These methods 
are laborious and time consuming. Over the past decade, numerous molecular 
techniques have been employed to identify and delineate NDV pathotypes:  PCR 
coupled to restriction enzyme digestion (Stauber et al., 1995); PCR-sequencing 
(Seal et al., 1995) and real-time PCR (Aldous and Alexander, 2001). Many of 
these techniques use the sequence of the F protein cleavage site as the basis to 
distinguish the virulent viruses from the avirulent ones.  The former contains a 
di-basic amino acid motif followed by a phenylalanine (F) residue within this 
site (RRQRR↓F) (Yusoff and Tan, 2001).  
 Tan et al. (2004a; 2007) developed a SYBR green I real time PCR technique 
to detect and distinguish the NDV pathotypes.  Pathotype-specific primers were 
designed to detect specific sequence of velogenic strains and lentogenic/vaccine 
strains, respectively. After establishing the optimum condition of the real time 
PCR, the assay was performed on 20 previously characterized NDV strains which 
included 8 velogenic field isolates, 4 lentogenic field isolates and 8 vaccine 
strains. When the velogenic-specific primer was used against the velogenic 
strains, it showed early amplification (Ct<24) with melting temperature at 86.0 
± 0.283°C. On the other hand, when the lentogenic-specific primer was tested 
against the lentogenic/vaccine strains, it showed early amplification (Ct<24) 
with melting temperature at 87.4 ± 0.207°C. 
 Ramanujam et al. (2002; 2004) and Tan et al. (2004c) suggested an 
alternative approach for the NDV pathotyping. It was shown that a filamentous 
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M13 bacteriophage displaying a peptide bearing the TLTTKLY sequence, 
isolated from a phage displayed peptide library against the velogenic NDV 
strain AF2240, could be used to differentiate velogenic NDV strains from 
mesogenic and lentogenic strains via a newly established indirect phage 
ELISA. The drawback of this method is that this phage could not be used as 
a capturing reagent in a dot blot assay or ELISA for detecting unpurified NDV 
samples, because the phage bound nonspecifically to host proteins in allantoic 
fluid. Since purifying the samples is often time consuming and laborious, this 
method is not feasible for screening large flocks of birds during an outbreak 
where fast and reliable results are required. To overcome this limitation, Lee 
et al. (2006) recently performed biopanning experiments by using a disulfide 
constrained phage displayed heptapeptide library against three pathotypes of 
NDV strains: velogenic (highly virulent), mesogenic (moderately virulent) and 
lentogenic (avirulent). A phage clone bearing the peptide sequence SWGEYDM 
capable of distinguishing virulent from avirulent NDV strains was isolated. This 
phage clone was employed as a diagnostic reagent in a dot blot assay and it 
successfully detected only virulent NDV strains.
VIrotherAPY As cAncer MedIcIne
It has been known since early last century that NDV has the ability to infect 
and kill cancer cells (reviewed by Sinkovics and Horvath, 2000). The virus 
exhibits selective growth in and killing of a variety of cancer cells.  This is 
because like similar to the life cycle of many other RNA viruses, the formation 
of double-stranded RNA (dsRNA) is integral in the replication and transcription 
of NDV.  It is well known that dsRNA activates a spectrum of cellular defense 
mechanisms including the activation of the RNA binding protein kinase (PKR) 
and the release of interferon α and β  (Williams, 1999).  It is thus not surprising 
that tumour cells, which are usually defective in PKR activation and interferon 
response pathways, tend to be permissive to NDV infection.  Moreover, its 
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replication occurs in the cytoplasm of host cells (Figure 8) and thus avoids the 
possibility of integration into the host genome which may result in deleterious 
complications.    
Figure 8   Effect of NDV infection in MCF-7 cancer cells.  (A) Confocal micrograph 
of NDV in the cytoplasm of the infected cells; (B) Apoptotic bodies observed in the 
infected cells (From Fauziah et al., 2004; Zolkapli et al., 2004)
 Advancements in reverse genetics has permitted the construction of 
recombinant NDV carrying transgenes such as the enhanced green fluorescent 
protein (EGFP) which can be retargeted to specific cancer cells (Kirn et al., 
2002; Zhao and Peeters, 2003; Bian et al., 2005).  It is therefore not surprising 
that the idea of NDV being used as an anti-cancer vaccine has been revived and 
its oncolytic properties studied in human clinical trials (Omar et al., 2003).  In 
many instances there were favorable results of partial to complete regression 
of tumors in various types of tumors including those in advanced stages that 
were not responsive to standard therapy (table 5).  The ability of NDV to 
selectively replicate in cancer cells is one of the most important features in the 
effectiveness of the virotherapy (Figure 9). Treatment with ATV in combination 
with a low-dose of recombinant interleukin-2 (IL-2) and interferon-alpha 2 
❚❘❘ 0
Newcastle Disease Virus: A Journey from Poultry to Cancer
(IFN-2a) was able to improve relapse-free and overall survival of patients with 
locally advanced renal cancer cells (Kirchner et al., 1995). 
table 5  Application of NDV as virotherapy against advanced tumours in clinical trials
Form and strain of ndV clinical  tumour targets
  Phase 
Live virus – PV701 I Advanced solid tumours
Live virus – MTH68/H - Advanced tumours of the renal, colon and 
breast
VO - Cassel II Stage II malignant melanoma
VO- Ulster II Advanced tumours of the renal, colon and 
breast
ATV - Cassel I Colorectal carcinoma (Dukes stage B2, C, 
D)
ATV - Cassel - Renal carcinoma
ATV – La Sota IV - Advanced tumours of digestive tract
ATV – PV701 III Breast carcinoma
 ATV = autologous live cell NDV modified tumour vaccine; VO = viral oncolysate (Modified from 
Omar et al. (2003)
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Figure 9  TEM micrograph of NDV-infected MCF-7 breast cancer cells at 12 hours 
post-infection. Note: virus particles (VP) and accumulation of nucleocapsids (N) in the 
cytoplasm. (Courtesy of Fauziah et al., 2004).
oncoLYtIc ndV-Induces APoPtosIs 
Some but not all NDV strains are known to evoke cellular apoptosis in cancer 
cells during infection (Figure 8). Apoptosis which is an energy-dependent 
process of cell suicide is also known as programmed cell death. It is a natural 
response of the cells when exposed to a variety of stimuli. Apoptotic cells 
have a characteristic morphology (Figure 10) and show distinct biochemical 
processes that can be detected using transmission electron microscope 
(Figures 11 and 12) and expression of apoptotic gene markers (Figure 
8) (Zolkapli et al., 2003; Fauziah et al., 2004). In general, the mechanisms 
associated with virus-induced apoptosis are associated with one or more of the 
host regulatory genes that function as an oncogene and/or tumour suppressor 
factor. Recently it has been shown that NDV cytotoxicity against tumor cells 
is due to multiple caspase-dependent pathways of apoptosis independent of 
interferon signaling competence. It is believed that NDV triggers apoptosis by 
activating the mitochondrial/intrinsic pathway and that it acts independently of 
the death receptor/extrinsic pathway (Elankumaran et al., 2006).
VP
n
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Figure 10  Confocal micrograph of cytoskeletal proteins of breast cancer cells treated 
with NDV (Courtesy of Zolkapli et al., 2003).
Figure 11  Scanning electron micrograph of MCF-7 breast cancer cell line untreated 
and treated (B) with AF2240 strain of NDV for 72 hours.  Notice the shrunken with 
blebbing plasma  membrane  of the treated cells (B).  (Courtesy of Fauziah et al., 
2004).
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Figure12  TEM pictures of control (A) and treated (C-F) MCF-7 for 6, 12, 24, 48 
and  72 hours respectively. Note the fragmented nucleus.  
(Courtesy of Fauziah et al., 2004).
oncLoYtIc MALAYsIAn IsoLAtes oF ndV
So far several different isolates of NDV have been isolated and characterized 
by researchers at UPM and the Veterinary Research Institute. In 2000, a 
collaborative project between UPM and USM, funded by the National Cancer 
Council (MAKNA), was launched with the primary target being the development 
of local NDV vaccines with oncolytic properties. The oncolytic effects of six 
(AF2240, 01/ C, Ijuk, S, F, V4) strains of NDV were screened on commercially 
available tumor cell lines, CEM-SS (T-lymphoblastic leukemic cells), MCF-7 
and MDA-231 (breast cancer), HT29 (colorectal cancer) and HL60 (acute 
promelocytic leukemia). Based on the colorimetric microtiter (MTT) cytotoxicity 
assay, strains AF2240, F and V4 showed significant oncolytic effects on MDA-
231 and MCF-7 cells whereas strain Ijuk showed significant killing of MDA-231 
cells only. Strain V4 also showed significant killing effect on the CEM-SS, HT29 
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and HL60 tumor cells. Compared to V4 and F, the strain AF2240 was far more 
superior in destroying breast cancer cells. In most cases, regardless of NDV 
strains and cancer cells, the oncolytic effects were demonstrated only on cancer 
cells but not on normal (3T3) cells. However, inactivation of NDV abrogates 
the oncolytic activity on cancer cells (Omar et al., 2003). Currently, studies are 
also underway in characterising the oncolytic effects of NDV strains AF2240. 
This local strain seems to have the potential to be developed as an anti-cancer 
agent for the treatment of cancer in humans.  In a study by Zulkapli et al. (2004) 
and Fauziah et al. (2004) it was observed  that strain AF2240 was able to infect 
MCF-7 cells resulting in apoptosis (Figures 8 and 9).  All of the three types 
of cytoskeletal proteins, actin, vimentin and tubulin, showed degradation after 
48 hours post-infection (Figure 10).  The cells also exhibited blebbing and 
nuclear fragmentation (Figures 11 and 12).
InhIbItIon oF VIrus rePLIcAtIon
One of the main drawbacks that limits the use of NDV in vivo anticancer 
treatment is that the virus binds to every cell, whether it is normal or a tumour 
cell since the sialic acid-containing receptors for the virus is ubiquitously 
expressed on cell surfaces.  As mentioned earlier, the virus shows preferential 
replication in tumour cells.  What happens if the virus mutates and causes 
systemic infection in humans? Is this going to be another newly re-emerging 
infectious disease? As a precautionary measure, we have constructed a novel 
therapeutic agent against NDV infection. Ramanujam et al. (2002), using 
filamentous bacteriophage M13 which displays random heptapeptide library on 
its PIII protein, showed that a fusion phage carrying the amino acid sequence 
TLTTKLY selected from the panning procedure, inhibited the propagation of 
NDV. An antibody competition assay revealed that the selected phage was 
capable of competing with the polyclonal antibodies raised against NDV for 
binding sites on the virus. Determination of the binding affinity of this phage 
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with NDV by an equilibrium binding assay in solution revealed two different 
dissociation constants, suggesting that there could be two distinct binding 
sites for the phage on NDV. Synthetic peptides with the sequence CTLTTKLYC, 
either in linear or cyclic conformations inhibited the binding of phage bearing 
the same sequence to NDV. These peptides also inhibited the hemolytic activity 
of the virus as well as its propagation (Figure 13) in embryonated chicken 
eggs (Ramanujam et al., 2002) as well as in mammalian cells (Ji et al., 2005). 
Hence the selected peptide may represent a lead anti viral compound for the 
treatment of viral infections.
Figure 13  Inhibition of NDV propagation with synthetic peptides. Both the peptides 
inhibited NDV propagation in embryonated eggs with the cyclic peptide being the better 
inhibitor. The experiment was performed twice in triplicate and the error bars represent 
the standard deviation of the mean of the two sets of experiments.  Cyclic peptide, 
 linear peptide, negative control  (Ramanujam et al., 2002)
 To delineate the structure-activity relationship of the peptide, CTLTTKLYC, 
mutational (alanine-substitution mutagenesis) and detailed molecular modeling 
studies based on NMR data were carried out (Chia et al., 2006). The peptide 
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displayed on the pIII protein of the filamentous M13 bacteriophage was 
synthesized and mutated in order to identify the amino acid residues involved 
in the interactions with NDV.  Mutations of C1 and K6 to A1 and A6 did not 
affect the binding significantly, but substitution of Y8 with A8 significantly 
reduced the interaction suggesting that Y8 plays an important role in the 
peptide-virus interaction.  The three-dimensional structure of the peptide was 
determined using circular dichroism (CD), nuclear magnetic resonance (NMR), 
and molecular modeling.  We showed that the peptide exhibited two possible 
conformers; a structure with consecutive β-turns or one with a β-hairpin bend 
(Figure 14).  Furthermore, the peptide in its cyclic form showed better activity 
than the linear peptide.  The first β-turn in the peptide may stabilize the overall 
peptide conformation and contribute to the activity whilst the second β-turn 
may expose the Y8 residue in proper orientation to the receptor for interaction 
with the surface proteins of the virus.
Figure 14. Proposed model for the cyclic peptide CTLTTKLYC. (A) Structure 
I represents an average structure from a family of structures that exhibits two 
consecutive β-turns. (B) Structure II represents an average structure of another family, 
which has β-hairpin bend type of conformation (From Chia et al., 2006).
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concLusIon
In this Professorial Inaugural Lecture I have presented the research on the 
Newcastle disease virus and its journey from poultry to cancer.  There are so 
many scientists worldwide working on the virus and the route undertaken to 
reach where we are today has been a long and tedious one.  We have had to 
cross many hurdles along the way and faced many setbacks but we will surely 
be successful one day. Where do we go from here?  The virus indeed exhibits 
very complex biological functions and interactions, the mechanism of many 
which are as yet unknown. NDV vaccines are now routinely used to control the 
disease in poultry, but have they got a new role now as a chemotherapeutic agent 
in humans?  Through reverse genetics could we now construct recombinant 
NDV vaccines or nanobiomolecules which can deliver specific drugs targeted 
at the cancer cells? What would be the mode of delivery of the viruses as 
chemotherapeutic agents? Other issues include biosafety, efficacy, feasibility and 
production costs required to produce therapeutic grade “human vaccines” as well 
as comparability and compatibility with other currently used chemotherapeutic 
agents or adjuvants. The pharmacodynamics and the pharmacokinetics need 
be worked out as well as efficient modes of delivery identified. It has indeed 
opened up a whole new area of scientific, clinical and biomedical engineering 
programmes which will prove to be challenging, but certainly exciting and 
potentially hugely rewarding.
 Another impeding hurdle will be public acceptance of using paramyxoviruses 
like NDV in virotherapy.  The functions and interactions of the paramyxoviral 
proteins with the cell are associated with severe diseases in humans and 
animals. In the last two decades, previously unidentified paramyxoviruses 
have emerged as the cause of serious disease outbreaks in a number of animal 
species including humans. Despite the considerable progress made, complete 
understanding of the viral pathogenesis has yet to be achieved. Therefore, more 
emphasis needs to be placed on analyzing individual viral components and 
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their interactions with each other and cellular factors to fully understand their 
biological functions. This information along with advances in biomolecular 
engineering such as reverse genetic technology, would generate possibilities for 
new pharmaceutical products that will have impact on the prevention, diagnosis 
and treatment of diseases.
 Let me end my Lecture by referring to Albert Einstein who made the following 
observations, “Madness is doing things over and over again, and expecting a 
different result” and “A discovery is said to be an accident meeting a prepared 
mind”. I would regard these observations as immutable truths in expeditions of 
scientific enquiry and we may well keep these as reminders along the voyage. 
My students who continue to push the boundaries of Science, would, as I have, 
appreciate these immutable truths. John F. Kennedy is famous for his saying 
“Don’t ask what your country can do for you but ask what you can do for your 
country.  But is was his brother, Robert who would embolden us scientists on 
this voyage into the unknown. He said, “Only those who dare to fail greatly can 
ever achieve greatly”.  Furthermore he said, “There are those who look at things 
the way they are, and ask why….I dream of things that never were, and ask why 
not?”  Despite being enunciated by a politician these can still be accepted as 
immutable truths by scientists!
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